EUVIMEDEUVIMED entdecken
Open Access

SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA

Isla E Emmen, William C Vuyk, Andrew J Lail, Sydney Wolf, Eli J O'Connor, Rhea Dalvie, Maansi Bhasin, Aanya Virdi, Caroline White, Nura R Hassan, Alex Richardson, Grace VanSleet und 11 weitere

Emerging Infectious Diseases · 2025-05 · 31 (13)

DOI: 10.3201/eid3113.241192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Emerging Infectious Diseases, 2025-05. Verfasst von Isla E Emmen und 22 weiteren Autor:innen. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Genome, Viral, COVID-19 Serological Testing. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the United States, SARS-CoV-2 genomic surveillance initially relied almost entirely on residual diagnostic specimens from nucleic acid amplification-based tests. However, use of those tests waned after the end of the COVID-19 Public Health Emergency on May 11, 2023. In Dane County, Wisconsin, we partnered with local- and state-level public health agencies and the South Central Library System to continue genomic surveillance by obtaining SARS-CoV-2 genome sequences from freely available community rapid antigen tests (RATs). During August 15, 2023-February 29, 2024, we received 227 RAT samples, from which we generated 127 sequences with >10× depth of coverage for >90% of the SARS-CoV-2 genome. In a subset of tests, lower cycle threshold values correlated with sequence success. Our results demonstrated that collecting and sequencing results from RATs in partnership with community sites is a practical approach for sustaining SARS-CoV-2 genomic surveillance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Genome, ViralCOVID-19 Serological TestingWisconsinHumansAntigens, Viral

Stichwörter der Autor:innen

COVID-19RNASARSSARS-CoV-2United StatesWisconsincoronaviruscoronavirus diseasepublic healthrespiratory infectionssevere acute respiratory syndrome coronavirus 2viruses

Substanzen

Antigens, Viral

Zitieren

APA

Emmen, I. E., Vuyk, W. C., Lail, A. J., Wolf, S., O'Connor, E. J., Dalvie, R., Bhasin, M., Virdi, A., White, C., Hassan, N. R., Richardson, A., VanSleet, G., Weiler, A., Rounds-Dunn, S., Van Horn, K., Gartler, M., Jorgenson, J., Spelman, M., Ottosen, S., …, & O'Connor, D. H. (2025). SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA. Emerging Infectious Diseases, 31(13). https://doi.org/10.3201/eid3113.241192

Vancouver

Emmen IE, Vuyk WC, Lail AJ, Wolf S, O'Connor EJ, Dalvie R, et al. SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA. Emerging Infectious Diseases. 2025;31(13). doi:10.3201/eid3113.241192

BibTeX
@article{Emmen2025,
  author = {Emmen, Isla E and Vuyk, William C and Lail, Andrew J and Wolf, Sydney and O'Connor, Eli J and Dalvie, Rhea and Bhasin, Maansi and Virdi, Aanya and White, Caroline and Hassan, Nura R and Richardson, Alex and VanSleet, Grace and Weiler, Andrea and Rounds-Dunn, Savannah and Van Horn, Kenneth and Gartler, Marc and Jorgenson, Jane and Spelman, Michael and Ottosen, Sean and Minor, Nicholas R and Wilson, Nancy and Friedrich, Thomas C and O'Connor, David H},
  title = {SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA},
  journal = {Emerging Infectious Diseases},
  year = {2025},
  volume = {31},
  number = {13},
  doi = {10.3201/eid3113.241192}
}
Kostenlos starten →